| 28 January 2026 |
New listings for NPM1 gene transcript monitoring and FISH. |
revision 2026.008 |
| 20 January 2026 |
Listings for infliximab and anti-infliximab antibody and adalimumab and anti-adalimumab antibody updated to match referral lab's current reporting. |
revision 2026.007 |
| 19 January 2026 | Fabry screen - added information on genetic testing. | revision 2026.006 |
| 14 January 2026 | Note added to platelet function studies to identify as Not UKAS Accredited. | revision 2026.005 |
| New revision of blood culture fill volumes poster - see taking blood cultures | revision 2026.004 | |
| 6 January 2026 | New page for Virology monthly performance data | revision 2026.003 |
| 5 January 2026 | Serum creatinine 8h stability limit removed. | revision 2026.002 |
| Updates to CSF microbiology. | revision 2026.001 |
From the end of 2025:
| 24 December 2025 |
Updates to ethylene glycol and methanol - an in-house service is now available on weekdays. |
revision 2025.068 |
| 17 December 2025 |
Addition of test indications and key factors affecting test performance or interpretation to: group and screen, antibody investigation / quantitation (transfusion), direct antiglobulin test (DAT), Kleihauer test, cold agglutinins, crossmatch, fetal Rh D testing and ROTEM. |
revision 2025.067 |
| Paroxysmal nocturnal haemoglobinuria - TAT updated and test indications added. |
revision 2025.066 |
|
| 15 December 2025 | CRP listing updated - minimum requesting interval restrictions implemented from 15/12/2025 |
revision 2025.065 |
Note some links in old pages may be broken where content has subsequently been removed and pages may have had further updates since those listed below.